Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancer

Overview of attention for article published in Radiation Oncology, February 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

blogs: 1 blog

twitter: 2 X users

Readers on

mendeley: 1 Mendeley

Summary Blogs X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 889 followers.

https://t.co/MJBopRu3GN

16 Feb 2024

Reply Repost Favourite

SABR is excellent alternative for medically inoperable pts with low risk of progression to severe or end-staged chronic kidney disease. Pre-treatment GFR is the strongest predictor of further decline in renal function. congrats to @_ShankarSiva and team!

16 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.